The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Drug Discovery Software Market Research Report 2024
Synopsis
Drug Discovery Software is a type of software that helps researchers and scientists to design, test, and optimize potential new drugs using computational methods and data analysis. Drug Discovery Software can provide features such as molecular modeling, virtual screening, docking, pharmacophore analysis, QSAR, ADMET prediction, and cheminformatics . Drug Discovery Software aims to help researchers and scientists accelerate the drug discovery process, reduce the cost and risk of failure, and discover novel and effective therapeutics .
The global Drug Discovery Software market was valued at US$ 178 million in 2023 and is anticipated to reach US$ 360.4 million by 2030, witnessing a CAGR of 10.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drug Discovery Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Discovery Software.
Report Scope
The Drug Discovery Software market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Discovery Software market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Discovery Software companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Epocrates
MicroTracker
DrugPatentWatch
PEPID PDC
AtomWise
InSilicoTrials
Thermo Scientific
AutoDock
CCD Vault
Compound Assist
DrugDev Spark
DSG Drug Safety
Segment by Type
Cloud Based
Web Based
Segment by Application
CROs and Universities
Companies
Testing Labs
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Discovery Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Drug Discovery Software is a type of software that helps researchers and scientists to design, test, and optimize potential new drugs using computational methods and data analysis. Drug Discovery Software can provide features such as molecular modeling, virtual screening, docking, pharmacophore analysis, QSAR, ADMET prediction, and cheminformatics . Drug Discovery Software aims to help researchers and scientists accelerate the drug discovery process, reduce the cost and risk of failure, and discover novel and effective therapeutics .
The global Drug Discovery Software market was valued at US$ 178 million in 2023 and is anticipated to reach US$ 360.4 million by 2030, witnessing a CAGR of 10.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drug Discovery Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Discovery Software.
Report Scope
The Drug Discovery Software market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Discovery Software market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Discovery Software companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Epocrates
MicroTracker
DrugPatentWatch
PEPID PDC
AtomWise
InSilicoTrials
Thermo Scientific
AutoDock
CCD Vault
Compound Assist
DrugDev Spark
DSG Drug Safety
Segment by Type
Cloud Based
Web Based
Segment by Application
CROs and Universities
Companies
Testing Labs
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Discovery Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Discovery Software Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Cloud Based
1.2.3 Web Based
1.3 Market by Application
1.3.1 Global Drug Discovery Software Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 CROs and Universities
1.3.3 Companies
1.3.4 Testing Labs
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Discovery Software Market Perspective (2019-2030)
2.2 Drug Discovery Software Growth Trends by Region
2.2.1 Global Drug Discovery Software Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Drug Discovery Software Historic Market Size by Region (2019-2024)
2.2.3 Drug Discovery Software Forecasted Market Size by Region (2025-2030)
2.3 Drug Discovery Software Market Dynamics
2.3.1 Drug Discovery Software Industry Trends
2.3.2 Drug Discovery Software Market Drivers
2.3.3 Drug Discovery Software Market Challenges
2.3.4 Drug Discovery Software Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Discovery Software Players by Revenue
3.1.1 Global Top Drug Discovery Software Players by Revenue (2019-2024)
3.1.2 Global Drug Discovery Software Revenue Market Share by Players (2019-2024)
3.2 Global Drug Discovery Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug Discovery Software Revenue
3.4 Global Drug Discovery Software Market Concentration Ratio
3.4.1 Global Drug Discovery Software Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Discovery Software Revenue in 2023
3.5 Drug Discovery Software Key Players Head office and Area Served
3.6 Key Players Drug Discovery Software Product Solution and Service
3.7 Date of Enter into Drug Discovery Software Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Discovery Software Breakdown Data by Type
4.1 Global Drug Discovery Software Historic Market Size by Type (2019-2024)
4.2 Global Drug Discovery Software Forecasted Market Size by Type (2025-2030)
5 Drug Discovery Software Breakdown Data by Application
5.1 Global Drug Discovery Software Historic Market Size by Application (2019-2024)
5.2 Global Drug Discovery Software Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Drug Discovery Software Market Size (2019-2030)
6.2 North America Drug Discovery Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Drug Discovery Software Market Size by Country (2019-2024)
6.4 North America Drug Discovery Software Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Discovery Software Market Size (2019-2030)
7.2 Europe Drug Discovery Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Drug Discovery Software Market Size by Country (2019-2024)
7.4 Europe Drug Discovery Software Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Discovery Software Market Size (2019-2030)
8.2 Asia-Pacific Drug Discovery Software Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Drug Discovery Software Market Size by Region (2019-2024)
8.4 Asia-Pacific Drug Discovery Software Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Discovery Software Market Size (2019-2030)
9.2 Latin America Drug Discovery Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Drug Discovery Software Market Size by Country (2019-2024)
9.4 Latin America Drug Discovery Software Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Discovery Software Market Size (2019-2030)
10.2 Middle East & Africa Drug Discovery Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Drug Discovery Software Market Size by Country (2019-2024)
10.4 Middle East & Africa Drug Discovery Software Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Epocrates
11.1.1 Epocrates Company Detail
11.1.2 Epocrates Business Overview
11.1.3 Epocrates Drug Discovery Software Introduction
11.1.4 Epocrates Revenue in Drug Discovery Software Business (2019-2024)
11.1.5 Epocrates Recent Development
11.2 MicroTracker
11.2.1 MicroTracker Company Detail
11.2.2 MicroTracker Business Overview
11.2.3 MicroTracker Drug Discovery Software Introduction
11.2.4 MicroTracker Revenue in Drug Discovery Software Business (2019-2024)
11.2.5 MicroTracker Recent Development
11.3 DrugPatentWatch
11.3.1 DrugPatentWatch Company Detail
11.3.2 DrugPatentWatch Business Overview
11.3.3 DrugPatentWatch Drug Discovery Software Introduction
11.3.4 DrugPatentWatch Revenue in Drug Discovery Software Business (2019-2024)
11.3.5 DrugPatentWatch Recent Development
11.4 PEPID PDC
11.4.1 PEPID PDC Company Detail
11.4.2 PEPID PDC Business Overview
11.4.3 PEPID PDC Drug Discovery Software Introduction
11.4.4 PEPID PDC Revenue in Drug Discovery Software Business (2019-2024)
11.4.5 PEPID PDC Recent Development
11.5 AtomWise
11.5.1 AtomWise Company Detail
11.5.2 AtomWise Business Overview
11.5.3 AtomWise Drug Discovery Software Introduction
11.5.4 AtomWise Revenue in Drug Discovery Software Business (2019-2024)
11.5.5 AtomWise Recent Development
11.6 InSilicoTrials
11.6.1 InSilicoTrials Company Detail
11.6.2 InSilicoTrials Business Overview
11.6.3 InSilicoTrials Drug Discovery Software Introduction
11.6.4 InSilicoTrials Revenue in Drug Discovery Software Business (2019-2024)
11.6.5 InSilicoTrials Recent Development
11.7 Thermo Scientific
11.7.1 Thermo Scientific Company Detail
11.7.2 Thermo Scientific Business Overview
11.7.3 Thermo Scientific Drug Discovery Software Introduction
11.7.4 Thermo Scientific Revenue in Drug Discovery Software Business (2019-2024)
11.7.5 Thermo Scientific Recent Development
11.8 AutoDock
11.8.1 AutoDock Company Detail
11.8.2 AutoDock Business Overview
11.8.3 AutoDock Drug Discovery Software Introduction
11.8.4 AutoDock Revenue in Drug Discovery Software Business (2019-2024)
11.8.5 AutoDock Recent Development
11.9 CCD Vault
11.9.1 CCD Vault Company Detail
11.9.2 CCD Vault Business Overview
11.9.3 CCD Vault Drug Discovery Software Introduction
11.9.4 CCD Vault Revenue in Drug Discovery Software Business (2019-2024)
11.9.5 CCD Vault Recent Development
11.10 Compound Assist
11.10.1 Compound Assist Company Detail
11.10.2 Compound Assist Business Overview
11.10.3 Compound Assist Drug Discovery Software Introduction
11.10.4 Compound Assist Revenue in Drug Discovery Software Business (2019-2024)
11.10.5 Compound Assist Recent Development
11.11 DrugDev Spark
11.11.1 DrugDev Spark Company Detail
11.11.2 DrugDev Spark Business Overview
11.11.3 DrugDev Spark Drug Discovery Software Introduction
11.11.4 DrugDev Spark Revenue in Drug Discovery Software Business (2019-2024)
11.11.5 DrugDev Spark Recent Development
11.12 DSG Drug Safety
11.12.1 DSG Drug Safety Company Detail
11.12.2 DSG Drug Safety Business Overview
11.12.3 DSG Drug Safety Drug Discovery Software Introduction
11.12.4 DSG Drug Safety Revenue in Drug Discovery Software Business (2019-2024)
11.12.5 DSG Drug Safety Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
